Cargando…
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide study
OBJECTIVE: Dabigatran was recently approved for anticoagulation in patients with atrial fibrillation (AF); data regarding real-world use, comparative effectiveness and safety are sparse. DESIGN: Pharmacoepidemiological cohort study. METHODS/SETTINGS: From nationwide registers, we identified patients...
Autores principales: | Sørensen, Rikke, Gislason, Gunnar, Torp-Pedersen, Christian, Olesen, Jonas Bjerring, Fosbøl, Emil L, Hvidtfeldt, Morten W, Karasoy, Deniz, Lamberts, Morten, Charlot, Mette, Køber, Lars, Weeke, Peter, Lip, Gregory Y H, Hansen, Morten Lock |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3646187/ https://www.ncbi.nlm.nih.gov/pubmed/23645926 http://dx.doi.org/10.1136/bmjopen-2013-002758 |
Ejemplares similares
-
Major Bleeding Complications and Persistence With Oral Anticoagulation in Non‐Valvular Atrial Fibrillation: Contemporary Findings in Real‐Life Danish Patients
por: Lamberts, Morten, et al.
Publicado: (2017) -
Temporal trends in initiation of VKA, rivaroxaban, apixaban and dabigatran for the treatment of venous thromboembolism - A Danish nationwide cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2017) -
Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study
por: Christiansen, Christine Benn, et al.
Publicado: (2013) -
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011–2015 in Denmark
por: Staerk, Laila, et al.
Publicado: (2016) -
Effect of government interventions to contain the COVID-19 pandemic on incidence of pulmonary embolism - A Danish nationwide register-based cohort study
por: Sindet-Pedersen, Caroline, et al.
Publicado: (2021)